...
首页> 外文期刊>European journal of gynaecological oncology >Sertoli-Leydig cell tumor characterized by hyperestrogenism in a postmenopausal woman: a case report and review of the literature
【24h】

Sertoli-Leydig cell tumor characterized by hyperestrogenism in a postmenopausal woman: a case report and review of the literature

机译:Sertoli-Leydig细胞肿瘤,其特征在于绝经后妇女:案例报告和文学审查

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Sertoli-Leydig cell tumor (SLCT) is a rare neoplasm from the group of sex-stromal tumors of ovary, which accounts for < 0.5% of all primary ovarian tumors. The tumor can occur in all ages but is more often seen in young women at the mean age of 25 years. Less than 10% of the SLCTs occur before menarche or after menopause. Although most SLCTs have a good prognosis if detected in Stage I, but the most common are those with moderate or poor differentiation. In order to monitor the risk of disease recurrence, close follow-up is required. In this article the rare case of SLCT in a 62-year-old woman characterized by postmenopausal bleeding and hyperestrogenism was reported, The clinical and pathological characteristics were described. Clinicians should consider that patients with postmenopausal bleeding and hyperestrogenism should be highly suspicious of SLCT, and more prospective studies on the diagnosis and the course of the diseases are needed.
机译:Sertoli-Leydig细胞肿瘤(SLCT)是来自卵巢的性质 - 基质肿瘤组的罕见肿瘤,其占所有原发性卵巢肿瘤的<0.5%。 肿瘤可能发生在所有年龄段中,但在25岁的平均年龄的年轻女性中更常见。 初期或更年期后,不到10%的SLCT会发生。 虽然如果在阶段I中检测到大多数SLCTS具有良好的预后,但最常见的是分化中度或差的人。 为了监测疾病复发的风险,需要紧密进行后续行动。 在本文中,报道了62岁女性中SLCT的罕见情况,据报道,临床和病理特征描述。 临床医生应考虑患有绝经后出血和高雌激素的患者应对SLCT非常可疑,并且需要对诊断和疾病过程进行更多的前瞻性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号